11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1

Details for Australian Patent Application No. 2006286568 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gillespie, Paul; Bilotta, Joseph Anthony; Fotouhi, Nader; Guertin, Kevin Richard; Tilley, Jefferson Wright; Thakkar, Kshitij Chhabilbhai; Hamilton, Matthew Michael; Scott, Nathan Robert; Mayweg, Alexander V.; Haynes, NancyEllen; Myers, Michael Paul; Kowalczyk, Agnieszka; Goodnow Jr., Robert Alan; Banner, Bruce Lester; Pietranico-Cole, Sherrie Lynn

Agent Spruson & Ferguson

Pub. Number AU-B-2006286568

PCT Pub. Number WO2007/025892

Priority 60/713,074 31.08.05 US; 60/817,255 29.06.06 US

Filing date 21 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 9 December 2010

International Classifications

C07D 231/54 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4184 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/025892 Priority application(s): WO2007/025892

9 December 2010 Application Accepted

  Published as AU-B-2006286568

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286569-A radiation curable ink jet ink and a method for printing a substrate with this ink

2006286563-Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis